Industry News
Doctors say HPV vaccine is safe and "grossly underutilized"
Jul 27, 2013
Amid parents' concern for their daughters over the timing and safety of vaccination shots against human papillomavirus (HPV), the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) have released a statement saying the vaccine is "safe, effective and grossly underutilized... Read More
Children with cancer receiving home care at greater risk for central line infections
Jul 27, 2013
Pediatric cancer patients whose central lines are used to treat them at home develop three times as many dangerous bloodstream infections from their devices than their hospitalized counterparts, according to the results of a new Johns Hopkins Children's Center study... Read More
Potential for new, less invasive ways to detect and treat bladder cancer
Jul 27, 2013
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression... Read More
Injectafer receives US FDA approval for the treatment of Iron Deficiency Anaemia
Jul 27, 2013
Injectafer® has received US Food and Drug Administration (FDA) approval for the treatment of Iron Deficiency Anaemia (IDA). Luitpold Pharmaceuticals, Inc., the US partner of Vifor Pharma, a company of the Galenica Group, will immediately launch the product. Injectafer® will be produced at the Luitpold manufacturing facility in Columbus, Ohio... Read More
Factors that link HPV and oesophageal cancer
Jul 26, 2013
The human papillomavirus (HPV) triples the risk of people developing yet another cancer, oesophageal squamous cell carcinoma (OSCC), according to research led by University of New South Wales (UNSW) academics. In addition to causing cervical, anal and genital cancers, HPV has more recently been found to cause some head and neck cancers... Read More
Gene test highly accurate in predicting metastasis in patients with thymoma
Jul 26, 2013
Patients diagnosed with thymoma, a rare cancer of the thymus gland, may be able to avoid certain cancer treatments associated with severe adverse events if the results of a new test reveal they are at low risk of metastasis, according to a study published today in the journal PLOS ONE... Read More
Factors that link HPV and oesophageal cancer
Jul 26, 2013
The human papillomavirus (HPV) triples the risk of people developing yet another cancer, oesophageal squamous cell carcinoma (OSCC), according to research led by University of New South Wales (UNSW) academics. In addition to causing cervical, anal and genital cancers, HPV has more recently been found to cause some head and neck cancers... Read More
Targeting HER1 receptor for peptide cancer vaccine, therapeutic agents
Jul 26, 2013
Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as possibly safer, more effective and less costly alternatives to the monoclonal-antibody-based drugs and small-molecule inhibitors now used to treat many malignancies. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
The worst bone tumors not found to be driven by pathways activated in most K9 bone tumors
Jul 26, 2013
Many cancers show inappropriate activation of a cell signaling pathway called NOTCH. In the developing body, NOTCH tells brain cells to grow and proliferate. It should be quiet in the adult body, but cancers restart NOTCH to drive their own growth, far and beyond the rate of healthy tissues... Read More
Combining oxygen with radiation therapy decelerates many cancer tumors
Jul 26, 2013
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement. In research examining tissue oxygenation levels and predicting radiation response, UT Southwestern scientists led by Dr... Read More
Previous Page Next Page